7th Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology

描述(由申请人提供)： 一年一度的美国心脏协会动脉硬化、血栓和血管生物学(ATVB)理事会春季会议与美国心脏协会营养、体力活动和新陈代谢(NPAM)理事会一起举行。这次会议的目的是将从事心血管疾病基础和临床方面工作的初级和高级科学家聚集在一起，以促进科学交流，以促进更快地吸收新知识。由于涵盖了ATVB和NPAM理事会涵盖的许多学科，这次会议具有更广泛的吸引力，有可能提供否则无法获得的交流和见解。这次会议的设计是为了鼓励互动和讨论，这次会议的一个关键组成部分是教育。会议的规模足够小，使学生和研究员能够与来自几个学科的知名国内和国际科学家一起积极参加海报和口头会议。总体而言，会议的具体目标是1)促进心血管疾病相关不同领域的研究人员之间交流科学信息和实验策略；2)确定和传播关于可促进所有领域研究的新技术的信息；3)加强基础科学研究成果向翻译/临床前研究并最终应用于临床的转移；4)为学生和研究员提供一个论坛，向有区别的受众展示数据，以鼓励他们在该领域的发展和保留；以及5)鼓励相关领域的研究人员相互了解并促进他们之间的科学合作。自2000年以来，该会议每年举行一次，与会者约有800人，其中包括约500名个人发言。规模保持不变，甚至随着时间的推移而增加的趋势被视为会议保证继续取得成功的迹象。

DESCRIPTION (provided by applicant): The annual Spring meeting of the Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB) Council of the American Heart Association is held together with the Nutrition, Physical Activity, and Metabolism (NPAM) Council of AHA. The meeting is intended to bring together junior and senior scientists working on basic and clinical aspects of cardiovascular disease for the purpose of advancing scientific interchange in order to facilitate a more rapid assimilation of new knowledge. By encompassing the many disciplines covered by the ATVB and NPAM councils, the meeting has a broader appeal that potentially provides interchanges and insights that would not otherwise become available. The design of the meeting is planned to encourage interaction and discussion and a key component of this meeting is educational. The size of the meeting is small enough to permit students and fellows to actively participate in poster and oral sessions together with well known national and international scientists from several disciplines. Overall, the specific aims of the conference are 1) to promote the exchange of scientific information and experimental strategies among investigators working in diverse areas pertinent to cardiovascular disease; 2) to identify and disseminate information about novel technologies that can advance research across all areas; 3) enhance the transfer of basic science findings into translational/preclinical studies and ultimately to clinical applications; 4) provide a forum for students and fellows to present data to a discriminating audience with an eye toward encouraging their development and retention in the field; and 5) to encourage investigators in related fields to become acquainted and to promote scientific collaborations among them. This meeting has been held annually since the year 2000, with attendance reaching about 800 participants including about 500 individual presentations. The trend for the size to remain constant and even increase with time is taken as a sign that continued success of the meeting is assured.